Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and ...
MIT researchers suggests a potential molecular strategy for treating fragile X syndrome by enhancing NMDA subunit function.
Building on more than two decades of research, a study by MIT neuroscientists at The Picower Institute for Learning and Memory reports a new way to treat pathology and symptoms of fragile X syndrome, ...
MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...
According to new research announced today, the fragile X syndrome (FXS) market across the USA and Germany is projected to ...
Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and improve our services and ads. If you agree, MSN and Microsoft Bing ...
US-based biopharmaceutical company Spinogenix has published top line outcomes from a Phase II trial of SPG601 for treating ...
Surging stock prices and house values have fueled a remarkable increase in household wealth. Household net worth — the ...
A growth occurring in the next five years will be fuelled by the launch of two high-priced pipeline products providing ...